Total Payments
$15,332
2024 Payments
$1,466
Companies
61
Transactions
501
Medicare Patients
17,978
Medicare Billing
$5.3M
Payment Breakdown by Category
Food & Beverage$11,267 (73.5%)
Education$2,565 (16.7%)
Other$1,500 (9.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,267 | 498 | 73.5% |
| Education | $2,565 | 2 | 16.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,500 | 1 | 9.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $4,125 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,556 | 114 | $0 (2024) |
| Amgen Inc. | $1,317 | 46 | $0 (2022) |
| Bard Peripheral Vascular, Inc. | $835.20 | 18 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $679.34 | 28 | $0 (2024) |
| ABIOMED | $467.43 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $427.31 | 25 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $370.08 | 32 | $0 (2024) |
| CVRx, Inc. | $338.74 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $331.29 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,466 | 59 | Novartis Pharmaceuticals Corporation ($366.48) |
| 2023 | $1,111 | 63 | Novartis Pharmaceuticals Corporation ($283.57) |
| 2022 | $3,477 | 52 | PFIZER INC. ($2,526) |
| 2021 | $1,641 | 70 | Bard Peripheral Vascular, Inc. ($448.26) |
| 2020 | $1,309 | 46 | Amgen Inc. ($252.69) |
| 2019 | $3,047 | 64 | PFIZER INC. ($1,518) |
| 2018 | $1,699 | 74 | ABIOMED ($430.01) |
| 2017 | $1,582 | 73 | Boehringer Ingelheim Pharmaceuticals, Inc. ($341.84) |
All Payment Transactions
501 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $30.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.69 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | CORDIS US CORP. | Mynx Venous VCD (Device) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $37.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | Abbott Laboratories | PERCLOSE PROSTYLE (Device) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Vascular | ||||||
| 10/22/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $34.54 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Structural Heart | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $25.94 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2024 | CORDIS US CORP. | Mynx Venous VCD (Device) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.61 | General |
| Category: Cardiovascular | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $15.42 | General |
| Category: Heart Failure and Hypertension | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 4,083 | 14,105 | $3.0M | $890,613 |
| 2022 | 44 | 4,036 | 14,836 | $3.1M | $918,130 |
| 2021 | 47 | 4,631 | 26,210 | $4.8M | $1.5M |
| 2020 | 57 | 5,228 | 33,594 | $6.6M | $2.0M |
Total Patients
17,978
Total Services
88,745
Medicare Billing
$5.3M
Procedure Codes
191
All Medicare Procedures & Services
191 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 591 | 1,734 | $554,880 | $163,905 | 29.5% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 111 | 111 | $417,693 | $130,472 | 31.2% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 111 | 222 | $221,556 | $71,003 | 32.0% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 105 | 107 | $229,515 | $66,707 | 29.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 146 | 146 | $161,330 | $47,987 | 29.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 307 | 307 | $151,044 | $43,560 | 28.8% |
| 37238 | Insertion of stent in vein with review by radiologist, initial vein | Office | 2023 | 11 | 16 | $141,088 | $42,780 | 30.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 214 | 856 | $126,688 | $37,242 | 29.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Office | 2023 | 42 | 42 | $112,854 | $32,361 | 28.7% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 29 | 35 | $97,545 | $29,571 | 30.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 147 | 294 | $82,908 | $26,527 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 299 | 422 | $95,794 | $23,675 | 24.7% |
| 36247 | Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | Office | 2023 | 17 | 19 | $69,483 | $19,529 | 28.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 126 | 138 | $64,446 | $19,371 | 30.1% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Office | 2023 | 20 | 26 | $63,258 | $19,236 | 30.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 261 | 261 | $45,936 | $13,368 | 29.1% |
| 93979 | Ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 109 | 150 | $43,800 | $13,128 | 30.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 67 | 67 | $40,267 | $12,199 | 30.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 76 | 77 | $36,652 | $10,667 | 29.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 63 | 63 | $35,217 | $10,343 | 29.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 408 | 546 | $19,656 | $5,562 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $17,724 | $4,698 | 26.5% |
| 37253 | Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | Office | 2023 | 16 | 34 | $14,620 | $4,633 | 31.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 85 | 108 | $13,608 | $4,237 | 31.1% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 35 | 43 | $12,771 | $3,904 | 30.6% |
About Dr. Sandeep Bajaj, M.D
Dr. Sandeep Bajaj, M.D is a Cardiovascular Disease healthcare provider based in Winter Park, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447254800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandeep Bajaj, M.D has received a total of $15,332 in payments from pharmaceutical and medical device companies, with $1,466 received in 2024. These payments were reported across 501 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($11,267).
As a Medicare-enrolled provider, Bajaj has provided services to 17,978 Medicare beneficiaries, totaling 88,745 services with total Medicare billing of $5.3M. Data is available for 4 years (2020–2023), covering 191 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Winter Park, FL
- Active Since 06/13/2005
- Last Updated 06/28/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1447254800
Products in Payments
- ELIQUIS (Drug) $4,337
- Repatha (Biological) $1,169
- ENTRESTO (Drug) $1,092
- Impella (Device) $467.43
- LEQVIO (Drug) $464.25
- JARDIANCE (Drug) $398.22
- VENOVO (Device) $340.07
- Barostim Neo System (Device) $338.74
- Rotarex (Device) $334.29
- XARELTO (Drug) $331.29
- MULTAQ (Drug) $287.63
- PRADAXA (Drug) $281.12
- NEXLETOL (Drug) $274.17
- VERQUVO (Drug) $268.47
- FFRct (Device) $191.49
- Cleerly Ischemia (Device) $152.87
- Corlanor (Drug) $147.86
- Zero Gravity (Device) $146.74
- Ablation Therapy Hardware (Device) $143.55
- PRALUENT (Drug) $139.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Winter Park
Dr. Usman Siddiqui, Md, MD
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Dr. Karan Reddy, M.d, M.D
Cardiovascular Disease — Payments: $41,494
Cardiovascular Disease $41,494
Dr. Milan Kothari, M.d, M.D
Cardiovascular Disease — Payments: $13,362
Cardiovascular Disease $13,362
Barton Sickinger, Do Facc, DO FACC
Cardiovascular Disease — Payments: $12,968
Cardiovascular Disease $12,968
Dr. Kunal Teli, M.d, M.D
Cardiovascular Disease — Payments: $7,814
Cardiovascular Disease $7,814
Dr. Harish Patil, M.d, M.D
Cardiovascular Disease — Payments: $5,478
Cardiovascular Disease $5,478